These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 18451234

  • 1. Profiling tumor-associated autoantibodies for the detection of colon cancer.
    Ran Y, Hu H, Zhou Z, Yu L, Sun L, Pan J, Liu J, Yang Z.
    Clin Cancer Res; 2008 May 01; 14(9):2696-700. PubMed ID: 18451234
    [Abstract] [Full Text] [Related]

  • 2. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
    Liu H, Zhang J, Wang S, Pang Z, Wang Z, Zhou W, Wu M.
    Cancer Epidemiol; 2012 Feb 01; 36(1):82-8. PubMed ID: 22018955
    [Abstract] [Full Text] [Related]

  • 3. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.
    Chang W, Wu L, Cao F, Liu Y, Ma L, Wang M, Zhao D, Li P, Zhang Q, Tan X, Yu Y, Lou Z, Zhao J, Zhang H, Fu C, Cao G.
    Clin Cancer Res; 2011 Sep 01; 17(17):5715-24. PubMed ID: 21771877
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer.
    Albanopoulos K, Armakolas A, Konstadoulakis MM, Leandros E, Tsiompanou E, Katsaragakis S, Alexiou D, Androulakis G.
    Am J Gastroenterol; 2000 Apr 01; 95(4):1056-61. PubMed ID: 10763959
    [Abstract] [Full Text] [Related]

  • 5. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K, Iida H, Endo H, Hosono K, Akiyama T, Takahashi H, Inamori M, Abe Y, Yoneda M, Fujita K, Kato S, Nozaki Y, Ichikawa Y, Uozaki H, Fukayama M, Shimamura T, Kodama T, Aburatani H, Miyazawa C, Ishii K, Hosomi N, Sagara M, Takahashi M, Ike H, Saito H, Kusakabe A, Nakajima A.
    Int J Oncol; 2009 Jul 01; 35(1):33-40. PubMed ID: 19513549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD, Snarska J, Jankowska A, Roszkowska-Jakimiec W, Puchalski Z, Zwierz K.
    Hepatogastroenterology; 2008 Jul 01; 55(82-83):388-93. PubMed ID: 18613372
    [Abstract] [Full Text] [Related]

  • 8. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M, Felix K, Hartmann D, Schnölzer M, Nees M, Vorderwülbecke S, Bogumil R, Büchler MW, Friess H.
    Pancreas; 2007 Mar 01; 34(2):205-14. PubMed ID: 17312459
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma.
    Tong YQ, Zhang ZJ, Liu B, Huang J, Liu H, Liu Y, Guo FJ, Zhou GH, Xie PL, Li YH, Zuo CH, Hu JY, Li GC.
    Proteomics; 2008 Aug 01; 8(15):3185-93. PubMed ID: 18654982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.
    Kalniņa Z, Siliņa K, Meistere I, Zayakin P, Rivosh A, Abols A, Leja M, Minenkova O, Schadendorf D, Linē A.
    J Immunol Methods; 2008 May 20; 334(1-2):37-50. PubMed ID: 18314130
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.
    Okada T, Akada M, Fujita T, Iwata T, Goto Y, Kido K, Okada T, Matsuzaki Y, Kobayashi K, Matsuno S, Sunamura M, Kawakami Y.
    Clin Cancer Res; 2006 Jan 01; 12(1):191-7. PubMed ID: 16397042
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K, Conrad T, Witzigmann H, Weimann A, Schütte C, Hauss J, Büchler M, Thiery J.
    Clin Cancer Res; 2009 Jun 01; 15(11):3812-9. PubMed ID: 19470732
    [Abstract] [Full Text] [Related]

  • 17. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma.
    Wang K, Xu X, Nie Y, Dai L, Wang P, Zhang J.
    Cancer Lett; 2009 Aug 28; 281(2):144-50. PubMed ID: 19304375
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
    Mroczko B, Kozłowski M, Groblewska M, Łukaszewicz M, Nikliński J, Jelski W, Laudański J, Chyczewski L, Szmitkowski M.
    Clin Chim Acta; 2008 Mar 28; 389(1-2):61-6. PubMed ID: 18155162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.